Status:

COMPLETED

Directly Observed Therapy for HIV Infected Adolescents

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Pediatric AIDS Clinical Trials Group

Conditions:

HIV Infections

Eligibility:

All Genders

16-25 years

Phase:

NA

Brief Summary

Adherence to a doctor-prescribed anti-HIV drug regimen is crucial in the management of HIV infection. In previous studies with tuberculosis patients, directly observed therapy (DOT), a strategy in whi...

Detailed Description

For HIV infected people, control of HIV infection is best achieved by adhering to the highly active antiretroviral therapy (HAART) regimen prescribed by their doctors. Poor adherence to a HAART regime...

Eligibility Criteria

Inclusion

  • Infected with HIV after age 12
  • Initiating, continuing, changing, or reinitiating a daily or twice-daily HAART regimen AND have demonstrated adherence problems (less than 85% of prescribed doses taken, as clinically disclosed, on 2 consecutive occasions at least 1 month apart). More information on this criterion can be found in the protocol.
  • Able and willing to swallow medication
  • Have access to HAART
  • Parent or guardian willing to provide informed consent, if applicable
  • Willing to use acceptable forms of contraception

Exclusion

  • Clinically significant diseases other than HIV infection or clinically significant findings during screening or physical examination that, in the opinion of the investigator, would require much closer follow-up and frequent monitoring than would be generally done for other HIV infected patients of comparable age
  • HAART regimens that include medications taken more often than twice-daily
  • Investigational agents (HAART or other medications) administered as part of other clinical trials
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2007

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00259389

Start Date

April 1 2006

End Date

September 1 2007

Last Update

September 18 2012

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Childrens Hospital Los Angeles

Los Angeles, California, United States, 90027

2

Los Angeles County Medical Center/USC

Los Angeles, California, United States, 90033

3

UCSD Mother, Child & Adolescent HIV Program

San Diego, California, United States, 92103

4

Childrens Hospital of Michigan

Detroit, Michigan, United States, 48201

Directly Observed Therapy for HIV Infected Adolescents | DecenTrialz